COMMUNIQUÉS West-GlobeNewswire

Grandevo® CG and Venerate® CG Approved for Use on Cannabis by the Colorado, Washington and Nevada Departments of Agriculture
30/04/2018
Grandevo and Venerate are Effective Tools for Controlling Mites and Insect Pests DAVIS, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based [...]
Yield10 Bioscience to Host Webcast of its First Quarter 2018 Conference Call
30/04/2018
WOBURN, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), a Company developing new technologies to achieve step-change improvements in crop yield that enhance global food security, [...]
Ultragenyx and Kyowa Kirin Announce Crysvita® (burosumab-twza) Now Launched in the U.S. for the Treatment of X–linked Hypophosphatemia (XLH) in Children and Adults
30/04/2018
First FDA-Approved Treatment that Targets the Underlying Cause of this Rare, Hereditary, Lifelong Disease UltraCare™ Program in Place to Provide Ongoing Patient Support NOVATO, Calif., TOKYO and LONDON, April 30, 2018 ( [...]
Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Charing Cross International Symposium 2018
30/04/2018
Charing Cross Symposium (CX) is the longest running vascular and endovascular symposium in Europe and one of the largest in the world REDWOOD CITY, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR [...]
Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin
30/04/2018
SAN DIEGO, April 30, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX ) (“Cytori” or “the Company”) today provided an update on its plans for US manufacturing and EU approval for its ATI-0918 liposomal [...]
Acology Secures Canadian Patent for MedTainer™
30/04/2018
CORONA, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) announced today that their signature product, the MedTainer, has been granted a Utility Patent from the Canadian Intellectual Property [...]
Imaging3 Announces Appointment of George Zdasiuk to Board of Directors
30/04/2018
Former CTO of Varian Medical Systems will also chair Imaging3 Scientific Advisory Board BURBANK, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Imaging 3 , Inc. (OTCQB:IGNG), a development stage company introducing [...]
Cellular Biomedicine Group Announces Results of 2018 Annual Meeting of Stockholders
30/04/2018
SHANGHAI, China and CUPERTINO, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc . (NASDAQ: CBMG ) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of [...]
Syneos Health Launches Catalyst Ophthalmology Site Network to Support Faster Start Up and Efficient Trial Delivery
30/04/2018
New Network Builds on Success of the Company’s Early Phase, Oncology, Psychiatry and Vaccine Catalyst Site Networks RALEIGH, N.C., April 30, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH ), the only fully [...]
Genocea Files Investigational New Drug Application for Neoantigen Cancer Vaccine Candidate GEN-009
30/04/2018
- C ompany plans to initiate Phase 1/2a clinical program later this year - - Top-line immune response data expected in the first half of 2019 - CAMBRIDGE, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, [...]
PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 7, 2018
30/04/2018
DELRAY BEACH, Fla., April 30, 2018 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS ) will announce its financial results for the fiscal year ended March 31, 2018 on Monday, May 7, 2018 at 8:00 A.M. Eastern Time, [...]
T2 Biosystems Announces 2018 First Quarter Financial and Operational Results Release and Conference Call Date
30/04/2018
LEXINGTON, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]
Inovio Pharmaceuticals to Report First Quarter 2018 Financial Results on May 9, 2018
30/04/2018
PLYMOUTH MEETING, Pa., April 30, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) announced today that it will host a conference call and live webcast to report its 2018 first quarter financial [...]
K2M Hosts the World’s Leading Spine Surgeons at Meeting of Minds™ 2018
30/04/2018
Clinical symposium in 3D spinal balance and cervical deformity correction reinforce K2M’s global commitment to advancing patient care LEESBURG, Va., April 30, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: [...]
Chimerix to Announce First Quarter 2018 Financial Results on May 7, 2018
30/04/2018
DURHAM, N.C., April 30, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that it will [...]
Keryx Biopharmaceuticals Announces Changes to Management and Preliminary First Quarter 2018 Revenue
30/04/2018
Gregory Madison resigned as president and chief executive officer of the company and from its board of directors Jodie Morrison, current Keryx board member, named interim chief executive officer Company expects to [...]
Sirona Biochem to Exhibit at the Shanghai China Beauty Expo 2018
30/04/2018
VANCOUVER, British Columbia, April 30, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM ) (FSE:ZSB) (the “ Company ”) announced today that they will be exhibitors at China Beauty Expo (CBE) 2018. The trade [...]
International Endeavors Corporation, a Medical Marijuana IP Holdings Company today announces the introduction of OGGL, OFF-GRID GROW LAB
30/04/2018
TEMECULA, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corporation (OTC:IDVV) is pleased to announce that After the appointment of new board member Andrew Read earlier this year [...]
Daré Bioscience announces funding award to further the development of Ovaprene™ from the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
30/04/2018
SAN DIEGO, April 30, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company, today announced that it received a Notice of Award for the first $224,665 of the [...]

Pages